Telemedicine solutions provider HeartBeam (NASDAQ:BEAT) continues to make price gains today after recent positive developments. This week, the company launched a video showcasing the HeartBeam AIMI and AIMIGo technologies and explaining the market opportunity.
BEAT plans to submit AIMIGo for clearance in the U.S. by the end of 2022.
Additionally, last week, BEAT was granted a patent in the U.S. for a 12-lead ECG patch monitor which opens an avenue for the company in Ischemia and Arrhythmia detection. The global ECG patch monitor market is expected to reach $4.8 billion by 2030.
BEAT shares are up almost 58% in the past 10 days.
Read full Disclosure